Pangaea Oncology, S.A. Stock BME
Equities
ES0105221008
Biotechnology & Medical Research
Sales 2024 * | 13.8M 15.03M 20.43M | Sales 2025 * | 14.8M 16.12M 21.91M | Capitalization | 54.18M 59M 80.21M |
---|---|---|---|---|---|
Net income 2024 * | -1M -1.09M -1.48M | Net income 2025 * | - 0 0 | EV / Sales 2024 * | 4.32 x |
Net Debt 2024 * | 5.5M 5.99M 8.14M | Net Debt 2025 * | 6.8M 7.4M 10.07M | EV / Sales 2025 * | 4.12 x |
P/E ratio 2024 * |
-36.8
x | P/E ratio 2025 * |
-92
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 21.08% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | - | 06-12-31 | |
Founder | - | 06-12-31 | |
Founder | - | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | - | 06-12-31 | |
Founder | - | 06-12-31 | |
Founder | - | 06-12-31 |
1st Jan change | Capi. | |
---|---|---|
+29.77% | 49.18B | |
+1.00% | 42.11B | |
+50.47% | 40.37B | |
-5.26% | 28.85B | |
+13.68% | 26.09B | |
-22.99% | 18.71B | |
+8.22% | 13.26B | |
+32.41% | 12.32B | |
-1.62% | 11.99B |